Evidence map›Paper›PMID 26594253›Full record

ArticleCellular and molecular bioengineering2015

EGF as a New Therapeutic Target for Medulloblastoma Metastasis.

Jennifer Rico-Varela, Tanya Singh, Sean McCutcheon, Maribel Vazquez

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular bioengineering, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Mechanistic insights into medulloblastoma relapse.Pharmacology & therapeutics · 2024
    Review
  2. Targeting Angiogenic Factors for the Treatment of Medulloblastoma.Current treatment options in oncology · 2022
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jennifer Rico-VarelaDepartment of Biomedical Engineering, The City College of New York, 160 Convent Avenue, ST-403D, New York, NY 10031.
Tanya SinghDepartment of Biomedical Engineering, The City College of New York, 160 Convent Avenue, ST-403D, New York, NY 10031.
Sean McCutcheonDepartment of Biomedical Engineering, The City College of New York, 160 Convent Avenue, ST-403D, New York, NY 10031.
Maribel VazquezDepartment of Biomedical Engineering, The City College of New York, 160 Convent Avenue, ST-403D, New York, NY 10031.
City University of New York · US

Funding

A mu Migration Assay for Temporal Protein LocalizationR21CA118255 · NCI · CITY COLLEGE OF NEW YORK · PI VAZQUEZ, MARIBEL · 2005 to 2006
$358k
Physical Science Oncology Center Training ProgramT32CA157323 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI HOLLAND, ERIC C., MICHOR, FRANZISKA · 2012 to 2012
$115k
NCI NIH HHS R21 CA118255NCI NIH HHS T32 CA157323
6 · The paper itself

Abstract

Medulloblastoma (MB) is a malignant pediatric brain tumor known for its aggressive metastatic potential. Despite the well-documented migration of MB cells to other parts of the brain and spinal column, MB chemotaxis is poorly understood. Herein, we examined the

Indexed as

chemotaxisgradientsmicrofluidicsPediatric cancer

Identifiers

PMID26594253
PMCPMC4648625
OpenAlexW976888095

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.